Skip to content

Boston Scientific BSX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Abbott logo
AbbottABT
TFX
TeleflexTFX
Merit Medical Systems logo
Merit Medical SystemsMMSI
Edwards Lifesciences logo
Edwards LifesciencesEW
Globus Medical logo
Globus MedicalGMED
ClearPoint Neuro logo
ClearPoint NeuroCLPT

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$65.77B-58.0%
P/E18.5×-44.2×
P/S3.2×-5.3×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's operating lease right-of-use assets in other assets?
Boston Scientific (BSX) reported operating lease right-of-use assets in other assets of $547M in Q1 2026.
How has Boston Scientific's operating lease right-of-use assets in other assets changed year-over-year?
Boston Scientific's operating lease right-of-use assets in other assets increased by 22.1% year-over-year, from $448M to $547M.
What is the long-term trend for Boston Scientific's operating lease right-of-use assets in other assets?
Over 5 years (2020 to 2025), Boston Scientific's operating lease right-of-use assets in other assets has grown at a 0.3% compound annual growth rate (CAGR), from $458M to $465M.